Non-Proliferative MDS
Showing 1 - 25 of >10,000
MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 16, 2023
Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)
Recruiting
- Leukemia
- +2 more
- Enasidenib mesylat dose escalation
-
Palo Alto, CaliforniaStanford Cancer Institute
May 12, 2022
Non Proliferative Diabetic Retinopathy(NPDR) Trial in Tianjin (pars plana vitrectomy(PPV), Pars plana vitrectomy(PPV)
Not yet recruiting
- Non Proliferative Diabetic Retinopathy(NPDR)
- pars plana vitrectomy(PPV)
- +2 more
-
Tianjin, ChinaTianjin medical university eye hospital
May 10, 2023
Non Proliferative Diabetic Retinopathy Trial in Seoul (Entelon Tab. 50mg, Placebo)
Recruiting
- Non Proliferative Diabetic Retinopathy
- Entelon Tab. 50mg
- Placebo
-
Seoul, Korea, Republic ofHallym University Kangnam Sacred Heart Hospital
Jul 19, 2022
Eyes With Non Proliferative Diabetic Retinopathy in Diabetes
Recruiting
- NPDR - Non Proliferative Diabetic Retinopathy
- +2 more
- Biomarkers
-
Dijon, France
- +4 more
Jul 18, 2022
Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection
Recruiting
- Mild Non-proliferative Diabetic Retinopathy
- +2 more
- Ranibizumab Injection [Lucentis]
- Phacoemulsification
-
Shanghai, Shanghai, ChinaDepartment of Ophthalmology, Ruijin Hospital Affiliated Medical,
May 18, 2022
Prophylactic PRP in Moderate NPDR
Completed
- Eye Diseases
- +2 more
- PRP
-
Assiut, EgyptAssiut University
Sep 14, 2022
Non-Proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (Faricimab)
Not yet recruiting
- Non-Proliferative Diabetic Retinopathy
-
Bakersfield, California
- +18 more
Jan 25, 2023
Dyslipidemia and Diabetic Retinopathy
Recruiting
- Diabetic Retinopathy
- Dyslipidemia
- 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
- Healthy Controls 15 age matched control subjects
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 11, 2022
MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,
Recruiting
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia
- CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
- Standard of Care Chemotherapy
-
Tampa, FloridaMoffitt Cancer Center
Sep 27, 2022
Breast Cancer Trial in Baltimore (Anastrozole, Letrozole)
Recruiting
- Breast Cancer
-
Baltimore, MarylandUniversity of Maryland Greenebaum Cancer Center
Apr 29, 2022
Non-proliferative Diabetic Retinopathy Trial in United States (OPL-0401 Dose 1, OPL-0401 Dose 2, Placebo)
Recruiting
- Non-proliferative Diabetic Retinopathy
- OPL-0401 Dose 1
- +2 more
-
Mountain View, California
- +20 more
Dec 16, 2022
Type2 Diabetes, Diabetic Retinopathy Trial in China (Tangningtongluo tablets, Calcium dobesilate capsules)
Recruiting
- Type2 Diabetes
- Diabetic Retinopathy
- Tangningtongluo tablets
- Calcium dobesilate capsules
-
Chongqing, Chongqing, China
- +9 more
Jun 27, 2022
Diabetic Retinopathy Trial in United Kingdom (Fenofibrate 145 mg, Placebo Oral Tablet)
Active, not recruiting
- Diabetic Retinopathy
- Fenofibrate 145 mg
- Placebo Oral Tablet
-
Aberdeen, United Kingdom
- +15 more
Jun 8, 2022
Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)
Active, not recruiting
- Non-proliferative Diabetic Retinopathy
- KSI-301
- Sham injection
-
Phoenix, Arizona
- +46 more
Sep 22, 2022
Proliferative Diabetic Retinopathy Trial in United States (Aflibercept)
Completed
- Proliferative Diabetic Retinopathy
-
Houston, Texas
- +3 more
May 20, 2021
NPDR - Non Proliferative Diabetic Retinopathy Trial in Coimbra (Laboratory tests)
Completed
- NPDR - Non Proliferative Diabetic Retinopathy
- Laboratory tests
-
Coimbra, PortugalAIBILI- Association for Biomedical Research and Inovation on Lig
Oct 11, 2022
Anti-VEGF in Real-world
Recruiting
- Neovascular Age-related Macular Edema
- +5 more
- Ranibizumab
- +2 more
-
Beijing, Beijing, ChinaWen-Bin Wei
Feb 2, 2022
Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial
Not yet recruiting
- Acute Myeloid Leukaemia (AML)
- +2 more
- (no location specified)
Sep 6, 2022
Non Proliferative Diabetic Retinopathy Trial in Guangzhou (Prompt panretinal photocoagulation, 25G Pars-plana vitrectomy)
Recruiting
- Non Proliferative Diabetic Retinopathy
- Prompt panretinal photocoagulation
- 25G Pars-plana vitrectomy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Apr 20, 2021